379 related articles for article (PubMed ID: 29762257)
21. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
[TBL] [Abstract][Full Text] [Related]
22. N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy.
Baskurt M; Okcun B; Abaci O; Dogan GM; Kilickesmez K; Ozkan AA; Ersanli M; Gurmen T
Eur J Clin Invest; 2009 Sep; 39(9):793-9. PubMed ID: 19500141
[TBL] [Abstract][Full Text] [Related]
23. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial.
Hölscher B; Heitmeyer C; Fobker M; Breithardt G; Schaefer RM; Reinecke H
Can J Cardiol; 2008 Nov; 24(11):845-50. PubMed ID: 18987758
[TBL] [Abstract][Full Text] [Related]
24. Feasibility study of the RenalGuard™ balanced hydration system: a novel strategy for the prevention of contrast-induced nephropathy in high risk patients.
Dorval JF; Dixon SR; Zelman RB; Davidson CJ; Rudko R; Resnic FS
Int J Cardiol; 2013 Jun; 166(2):482-6. PubMed ID: 22204847
[TBL] [Abstract][Full Text] [Related]
25. Patients at risk for contrast-induced nephropathy and mid-term effects after contrast administration: a prospective cohort study.
Moos SI; Nagan G; de Weijert RS; van Vemde DN; Stoker J; Bipat S
Neth J Med; 2014 Sep; 72(7):363-71. PubMed ID: 25178770
[TBL] [Abstract][Full Text] [Related]
26. Incidence of contrast-induced nephropathy in kidney transplant recipients.
Haider M; Yessayan L; Venkat KK; Goggins M; Patel A; Karthikeyan V
Transplant Proc; 2015 Mar; 47(2):379-83. PubMed ID: 25769577
[TBL] [Abstract][Full Text] [Related]
27. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention.
Jurado-Román A; Hernández-Hernández F; García-Tejada J; Granda-Nistal C; Molina J; Velázquez M; Albarrán A; Tascón J
Am J Cardiol; 2015 May; 115(9):1174-8. PubMed ID: 25759106
[TBL] [Abstract][Full Text] [Related]
28. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.
Stacul F; van der Molen AJ; Reimer P; Webb JA; Thomsen HS; Morcos SK; Almén T; Aspelin P; Bellin MF; Clement O; Heinz-Peer G;
Eur Radiol; 2011 Dec; 21(12):2527-41. PubMed ID: 21866433
[TBL] [Abstract][Full Text] [Related]
29. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
Vasheghani-Farahani A; Sadigh G; Kassaian SE; Khatami SM; Fotouhi A; Razavi SA; Mansournia MA; Yamini-Sharif A; Amirzadegan A; Salarifar M; Sadeghian S; Davoodi G; Borumand MA; Esfehani FA; Darabian S
Am J Kidney Dis; 2009 Oct; 54(4):610-8. PubMed ID: 19619921
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Dussol B; Morange S; Loundoun A; Auquier P; Berland Y
Nephrol Dial Transplant; 2006 Aug; 21(8):2120-6. PubMed ID: 16611682
[TBL] [Abstract][Full Text] [Related]
31. Serum creatinine measurements: evaluation of a questionnaire according to the ESUR guidelines.
Zähringer C; Potthast S; Tyndall AJ; Bongartz G; Hohmann J
Acta Radiol; 2015 May; 56(5):628-34. PubMed ID: 24867223
[TBL] [Abstract][Full Text] [Related]
32. Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.
Wang J; Ai X; Li L; Gao Y; Sun N; Li C; Sun W
Int Urol Nephrol; 2017 Nov; 49(11):2019-2026. PubMed ID: 28656510
[TBL] [Abstract][Full Text] [Related]
33. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
[TBL] [Abstract][Full Text] [Related]
34. Safe use of iodinated and gadolinium-based contrast media in current practice in Japan: a questionnaire survey.
Tsushima Y; Ishiguchi T; Murakami T; Hayashi H; Hayakawa K; Fukuda K; Korogi Y; Sugimoto H; Takehara Y; Narumi Y; Arai Y; Kuwatsuru R; Yoshimitsu K; Awai K; Kanematsu M; Takagi R
Jpn J Radiol; 2016 Feb; 34(2):130-9. PubMed ID: 26662468
[TBL] [Abstract][Full Text] [Related]
35. Prevention of Contrast-induced Nephropathy With Oxygen Supplementation: a Randomized Controlled Trial.
Minoo F; Lessan-Pezeshki M; Firouzi A; Nikfarjam S; Gatmiri SM; Ramezanzade E
Iran J Kidney Dis; 2016 Sep; 10(5):291-298. PubMed ID: 27721227
[TBL] [Abstract][Full Text] [Related]
36. Remote Ischemic Preconditioning To Reduce Contrast-Induced Nephropathy: A Randomized Controlled Trial.
Menting TP; Sterenborg TB; de Waal Y; Donders R; Wever KE; Lemson MS; van der Vliet JA; Wetzels JF; SchultzeKool LJ; Warlé MC
Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):527-32. PubMed ID: 26015372
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
Reed PS; Dixon SR; Boura JA; O'Neill WW; Kahn JK
Am J Cardiol; 2007 Oct; 100(7):1090-3. PubMed ID: 17884368
[TBL] [Abstract][Full Text] [Related]
38. 20-Hour preprocedural hydration is not superior to 5-hour preprocedural hydration in the prevention of contrast-induced increases in serum creatinine and cystatin C.
Torigoe K; Tamura A; Watanabe T; Kadota J
Int J Cardiol; 2013 Sep; 167(5):2200-3. PubMed ID: 22717305
[TBL] [Abstract][Full Text] [Related]
39. Contrast-medium-Induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min.
Nyman U; Almén T; Aspelin P; Hellström M; Kristiansson M; Sterner G
Acta Radiol; 2005 Dec; 46(8):830-42. PubMed ID: 16392608
[TBL] [Abstract][Full Text] [Related]
40. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
Thayssen P; Lassen JF; Jensen SE; Hansen KN; Hansen HS; Christiansen EH; Junker A; Ravkilde J; Thuesen L; Veien KT; Jensen LO
Circ Cardiovasc Interv; 2014 Apr; 7(2):216-24. PubMed ID: 24714489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
